These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21786579)

  • 21. Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients.
    Abou-Mrad RM; Abu-Alfa AK; Ziyadeh FN
    Am J Physiol Renal Physiol; 2013 Sep; 305(5):F613-7. PubMed ID: 23825072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal disease in patients with massive obesity.
    Kasiske BL; Crosson JT
    Arch Intern Med; 1986 Jun; 146(6):1105-9. PubMed ID: 3718096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orlistat and calcium oxalate crystalluria: an association that needs consideration.
    Ahmed MH
    Ren Fail; 2010; 32(8):1019-21. PubMed ID: 20722574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progression factors in chronic kidney disease. Non-immunological mechanisms].
    Fernández Fresnedo G; Sánchez Plumed J; Arias M; Del Castillo Caba D; López Oliva MO
    Nefrologia; 2009; 29 Suppl 1():16-24. PubMed ID: 19675657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The importance of overweight and obesity for the development and progression of renal diseases].
    Klassen A; Bahner U; Sebekova K; Heidland A
    Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412
    [No Abstract]   [Full Text] [Related]  

  • 27. Lifestyle factors, obesity and the risk of chronic kidney disease.
    Stengel B; Tarver-Carr ME; Powe NR; Eberhardt MS; Brancati FL
    Epidemiology; 2003 Jul; 14(4):479-87. PubMed ID: 12843775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?
    Hallan S; de Mutsert R; Carlsen S; Dekker FW; Aasarød K; Holmen J
    Am J Kidney Dis; 2006 Mar; 47(3):396-405. PubMed ID: 16490617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and kidney disease: a big dilemma.
    Kramer H; Luke A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):237-41. PubMed ID: 17420667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity: what impact on renal function?].
    Mathieu C; Teta D; Vogt B; Burnier M
    Rev Med Suisse; 2006 Mar; 2(55):576-8, 580-1. PubMed ID: 16562600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight loss: a neglected intervention in the management of chronic kidney disease.
    Ibrahim HN; Weber ML
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):534-8. PubMed ID: 20827193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular pathogenesis of chronic kidney disease].
    Kashihara N; Satoh M
    Nihon Rinsho; 2008 Sep; 66(9):1671-7. PubMed ID: 18788393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Fatty Kidney: Obesity and Renal Disease.
    Praga M; Morales E
    Nephron; 2017; 136(4):273-276. PubMed ID: 27414023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity related kidney disease.
    Mathew AV; Okada S; Sharma K
    Curr Diabetes Rev; 2011 Jan; 7(1):41-9. PubMed ID: 21067508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overweight, obesity and metabolic alterations in chronic kidney disease.
    Zoccali C
    Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.